Materials & Resources » Chemicals | Aceto Corp.

Aceto Corp. | Cash Flow

Fiscal year is July-June. All values USD Thousands.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
22,328.00
29,000.00
33,483.00
34,766.00
11,376.00
Depreciation, Depletion & Amortization
6,944.00
8,091.00
11,849.00
14,011.00
24,657.00
Other Funds
851.00
252.00
7,210.00
14,190.00
4,861.00
Funds from Operations
30,274.00
35,148.00
44,868.00
55,916.00
51,065.00
Changes in Working Capital
6,543.00
10,092.00
36,525.00
24,085.00
6,498.00
Net Operating Cash Flow
23,731.00
25,056.00
8,343.00
31,831.00
44,567.00
Capital Expenditures
2,527.00
1,891.00
2,181.00
12,377.00
5,252.00
Purchase/Sale of Investments
1,076.00
1,398.00
2,720.00
2,483.00
1,126.00
Net Investing Cash Flow
1,451.00
86,633.00
4,901.00
9,894.00
276,378.00
Cash Dividends Paid - Total
6,016.00
6,806.00
6,964.00
7,084.00
7,831.00
Issuance/Reduction of Debt, Net
13,696.00
73,432.00
4,656.00
31,400.00
232,303.00
Net Financing Cash Flow
14,306.00
70,533.00
8,245.00
10,855.00
220,162.00
Net Change in Cash
8,369.00
9,666.00
8,877.00
32,808.00
11,148.00
Free Cash Flow
22,709.00
23,911.00
7,726.00
30,703.00
42,674.00
Deferred Taxes & Investment Tax Credit
2,649.00
3,083.00
1,874.00
18.00
504.00
Net Assets from Acquisitions
-
86,140.00
-
-
270,000.00
Change in Capital Stock
6,257.00
3,655.00
1,273.00
729.00
551.00
Exchange Rate Effect
395.00
710.00
4,074.00
16.00
501.00

About Aceto

View Profile
Address
4 Tri Harbor Court
Port Washington New York 11050
United States
Employees -
Website http://www.aceto.com
Updated 09/14/2018
Aceto Corp. engages in the development, marketing, sales, and distribution of chemical compounds used in the pharmaceutical, nutraceutical, agricultural, coatings, and industrial chemical industries. It operates through the following segments: Human Health, Pharmaceutical Ingredients and Performance Chemicals. The Human Health segment develops and sells finished dosage form generic drugs and nutraceutical products.